Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D9203
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 48 $55,071 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $55,071 Current and potential, with all options
- Last date to order 10% complete
- IDV ceiling 1% used
- $4,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, covers a wide range of pharmaceutical products and medical supplies to support the medical needs of Department of Defense (DoD) healthcare facilities and the U.S. Coast Guard. The single-award Indefinite Delivery Contract (IDC), valued at $499,999,999 and valid through November 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.
The original solicitation, expected to be issued in March 2024, seeks to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to DoD customers, including the Defense Health Agency, United States Coast Guard, and U.S. Naval Fleet. The procurement is an unrestricted, fully competitive acquisition with a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. Awards will be made on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items, ensuring resiliency in the federal pharmaceutical supply chain.
Task orders
Show all 48
Quick answers
Who was awarded contract SPE2DR25D9203?
SPE2DR25D9203 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 1, 2025.
How much is contract SPE2DR25D9203 worth?
Orders under SPE2DR25D9203 have obligated $55,071. SPE2DR25D9203's own ceiling is $4,999,999.
How many orders have been placed under contract SPE2DR25D9203?
48 orders have been placed under SPE2DR25D9203, the latest on July 27, 2026.
Who can order from contract SPE2DR25D9203?
SPE2DR25D9203 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D9203 competed?
The extent of competition for SPE2DR25D9203 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV